Long-term experience with endovascular therapy of the descending thoracic aorta
Background To review single centre experience of endovascular treatment of descending thoracic aorta. Methods Between May 1999 and September 2012, 72 patients were treated overall (53 men, 19 women, mean age 60.1 years) for degenerative aneurysms (n = 5), ruptured aneurysms (n = 4), aortic ulcers (n...
Gespeichert in:
| Veröffentlicht in: | Central European journal of medicine 2013-04, Vol.8 (2), p.257-265 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 265 |
|---|---|
| container_issue | 2 |
| container_start_page | 257 |
| container_title | Central European journal of medicine |
| container_volume | 8 |
| creator | Raupach, Jan Vojacek, Jan Lojik, Miroslav Harrer, Jan Chovanec, Vendelin Ferko, Alexander Hoffmann, Petr Ryška, Pavel Renc, Ondrej Krajina, Antonin |
| description | Background
To review single centre experience of endovascular treatment of descending thoracic aorta.
Methods
Between May 1999 and September 2012, 72 patients were treated overall (53 men, 19 women, mean age 60.1 years) for degenerative aneurysms (n = 5), ruptured aneurysms (n = 4), aortic ulcers (n = 8), infected aneurysms (n = 4), type B aortic dissections (n = 23), and traumatic aortic injuries (n = 28).
Results
The technical success rate was 98.6%, 30-day mortality was 8.3%, 1-year mortality was 13.8%, and overall mortality was 22.2%. Mortality caused by the treatment of aortic diseases was 6.9%. Permanent stroke occurred in 1 patient, and paraplegia developed in 1 patient. In a group of 23 patients whose left subclavian artery (LSA) was covered, claudication of the left upper extremity developed in 2 cases.
Conclusions
Endovascular therapy offers a very effective and less invasive alternative to the surgical approach for a wide range of the thoracic aortic disease. The main advantage of using TEVAR seems to be in acute conditions when a stent graft stabilizes the aorta and prevents further bleeding and organ ischemia. Regular follow-up is mandatory for early recognition of specific TEVAR complications. |
| doi_str_mv | 10.2478/s11536-012-0117-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1271850489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2871166191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-9eee2cc199c944860fbd8d03ac452d233bd6b65cc1d7a1f0825720d4cfa860ca3</originalsourceid><addsrcrecordid>eNqNUMtKxDAUDaLgOPoB7gquo3k1TTeCDL5gYDa6Dpkk7XSYaWrSOvbvvUNduBFcXO655DzCQeiaklsmCnWXKM25xIQyGFpgeYJmVAqBuRTkFLAqc0xJrs7RRUpbQiQpSjVDq2Voa9z7uM_8V-dj41vrs0PTbzLfuvBpkh12Jmb9xkfTjVmojjBzPll4b9oazhCNbWxmQuzNJTqrzC75q589R-9Pj2-LF7xcPb8uHpbYcil7XHrvmbW0LG0phJKkWjvlCDdW5MwxztdOrmUODFcYWhHF8oIRJ2xlgGwNn6ObybeL4WPwqdfbMMQWIjVlBVU5EaoEFp1YNoaUoq90F5u9iaOmRB9701NvGnrTx960BM39pDmYHfTifB2HEcCvgL-0isE3wYBNBgnC2vpfSv4N4VGEyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1271850489</pqid></control><display><type>article</type><title>Long-term experience with endovascular therapy of the descending thoracic aorta</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Walter De Gruyter: Open Access Journals</source><source>Alma/SFX Local Collection</source><creator>Raupach, Jan ; Vojacek, Jan ; Lojik, Miroslav ; Harrer, Jan ; Chovanec, Vendelin ; Ferko, Alexander ; Hoffmann, Petr ; Ryška, Pavel ; Renc, Ondrej ; Krajina, Antonin</creator><creatorcontrib>Raupach, Jan ; Vojacek, Jan ; Lojik, Miroslav ; Harrer, Jan ; Chovanec, Vendelin ; Ferko, Alexander ; Hoffmann, Petr ; Ryška, Pavel ; Renc, Ondrej ; Krajina, Antonin</creatorcontrib><description>Background
To review single centre experience of endovascular treatment of descending thoracic aorta.
Methods
Between May 1999 and September 2012, 72 patients were treated overall (53 men, 19 women, mean age 60.1 years) for degenerative aneurysms (n = 5), ruptured aneurysms (n = 4), aortic ulcers (n = 8), infected aneurysms (n = 4), type B aortic dissections (n = 23), and traumatic aortic injuries (n = 28).
Results
The technical success rate was 98.6%, 30-day mortality was 8.3%, 1-year mortality was 13.8%, and overall mortality was 22.2%. Mortality caused by the treatment of aortic diseases was 6.9%. Permanent stroke occurred in 1 patient, and paraplegia developed in 1 patient. In a group of 23 patients whose left subclavian artery (LSA) was covered, claudication of the left upper extremity developed in 2 cases.
Conclusions
Endovascular therapy offers a very effective and less invasive alternative to the surgical approach for a wide range of the thoracic aortic disease. The main advantage of using TEVAR seems to be in acute conditions when a stent graft stabilizes the aorta and prevents further bleeding and organ ischemia. Regular follow-up is mandatory for early recognition of specific TEVAR complications.</description><identifier>ISSN: 1895-1058</identifier><identifier>ISSN: 2391-5463</identifier><identifier>EISSN: 1644-3640</identifier><identifier>EISSN: 2391-5463</identifier><identifier>DOI: 10.2478/s11536-012-0117-6</identifier><language>eng</language><publisher>Heidelberg: SP Versita</publisher><subject>Aneurysm ; Aortic trauma ; Biomedicine ; Complications ; Dissection ; Internal Medicine ; Maternal and Child Health ; Medicine ; Medicine & Public Health ; Reproductive Medicine ; Research Article ; Stent graft ; Surgery ; Thoracic aorta</subject><ispartof>Central European journal of medicine, 2013-04, Vol.8 (2), p.257-265</ispartof><rights>Versita Warsaw and Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c366t-9eee2cc199c944860fbd8d03ac452d233bd6b65cc1d7a1f0825720d4cfa860ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.degruyter.com/document/doi/10.2478/s11536-012-0117-6/pdf$$EPDF$$P50$$Gwalterdegruyter$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.degruyter.com/document/doi/10.2478/s11536-012-0117-6/html$$EHTML$$P50$$Gwalterdegruyter$$Hfree_for_read</linktohtml><link.rule.ids>315,782,786,27933,27934,67167,68951</link.rule.ids></links><search><creatorcontrib>Raupach, Jan</creatorcontrib><creatorcontrib>Vojacek, Jan</creatorcontrib><creatorcontrib>Lojik, Miroslav</creatorcontrib><creatorcontrib>Harrer, Jan</creatorcontrib><creatorcontrib>Chovanec, Vendelin</creatorcontrib><creatorcontrib>Ferko, Alexander</creatorcontrib><creatorcontrib>Hoffmann, Petr</creatorcontrib><creatorcontrib>Ryška, Pavel</creatorcontrib><creatorcontrib>Renc, Ondrej</creatorcontrib><creatorcontrib>Krajina, Antonin</creatorcontrib><title>Long-term experience with endovascular therapy of the descending thoracic aorta</title><title>Central European journal of medicine</title><addtitle>cent.eur.j.med</addtitle><description>Background
To review single centre experience of endovascular treatment of descending thoracic aorta.
Methods
Between May 1999 and September 2012, 72 patients were treated overall (53 men, 19 women, mean age 60.1 years) for degenerative aneurysms (n = 5), ruptured aneurysms (n = 4), aortic ulcers (n = 8), infected aneurysms (n = 4), type B aortic dissections (n = 23), and traumatic aortic injuries (n = 28).
Results
The technical success rate was 98.6%, 30-day mortality was 8.3%, 1-year mortality was 13.8%, and overall mortality was 22.2%. Mortality caused by the treatment of aortic diseases was 6.9%. Permanent stroke occurred in 1 patient, and paraplegia developed in 1 patient. In a group of 23 patients whose left subclavian artery (LSA) was covered, claudication of the left upper extremity developed in 2 cases.
Conclusions
Endovascular therapy offers a very effective and less invasive alternative to the surgical approach for a wide range of the thoracic aortic disease. The main advantage of using TEVAR seems to be in acute conditions when a stent graft stabilizes the aorta and prevents further bleeding and organ ischemia. Regular follow-up is mandatory for early recognition of specific TEVAR complications.</description><subject>Aneurysm</subject><subject>Aortic trauma</subject><subject>Biomedicine</subject><subject>Complications</subject><subject>Dissection</subject><subject>Internal Medicine</subject><subject>Maternal and Child Health</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Reproductive Medicine</subject><subject>Research Article</subject><subject>Stent graft</subject><subject>Surgery</subject><subject>Thoracic aorta</subject><issn>1895-1058</issn><issn>2391-5463</issn><issn>1644-3640</issn><issn>2391-5463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNUMtKxDAUDaLgOPoB7gquo3k1TTeCDL5gYDa6Dpkk7XSYaWrSOvbvvUNduBFcXO655DzCQeiaklsmCnWXKM25xIQyGFpgeYJmVAqBuRTkFLAqc0xJrs7RRUpbQiQpSjVDq2Voa9z7uM_8V-dj41vrs0PTbzLfuvBpkh12Jmb9xkfTjVmojjBzPll4b9oazhCNbWxmQuzNJTqrzC75q589R-9Pj2-LF7xcPb8uHpbYcil7XHrvmbW0LG0phJKkWjvlCDdW5MwxztdOrmUODFcYWhHF8oIRJ2xlgGwNn6ObybeL4WPwqdfbMMQWIjVlBVU5EaoEFp1YNoaUoq90F5u9iaOmRB9701NvGnrTx960BM39pDmYHfTifB2HEcCvgL-0isE3wYBNBgnC2vpfSv4N4VGEyg</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Raupach, Jan</creator><creator>Vojacek, Jan</creator><creator>Lojik, Miroslav</creator><creator>Harrer, Jan</creator><creator>Chovanec, Vendelin</creator><creator>Ferko, Alexander</creator><creator>Hoffmann, Petr</creator><creator>Ryška, Pavel</creator><creator>Renc, Ondrej</creator><creator>Krajina, Antonin</creator><general>SP Versita</general><general>Versita</general><general>Walter de Gruyter GmbH</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope></search><sort><creationdate>20130401</creationdate><title>Long-term experience with endovascular therapy of the descending thoracic aorta</title><author>Raupach, Jan ; Vojacek, Jan ; Lojik, Miroslav ; Harrer, Jan ; Chovanec, Vendelin ; Ferko, Alexander ; Hoffmann, Petr ; Ryška, Pavel ; Renc, Ondrej ; Krajina, Antonin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-9eee2cc199c944860fbd8d03ac452d233bd6b65cc1d7a1f0825720d4cfa860ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aneurysm</topic><topic>Aortic trauma</topic><topic>Biomedicine</topic><topic>Complications</topic><topic>Dissection</topic><topic>Internal Medicine</topic><topic>Maternal and Child Health</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Reproductive Medicine</topic><topic>Research Article</topic><topic>Stent graft</topic><topic>Surgery</topic><topic>Thoracic aorta</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raupach, Jan</creatorcontrib><creatorcontrib>Vojacek, Jan</creatorcontrib><creatorcontrib>Lojik, Miroslav</creatorcontrib><creatorcontrib>Harrer, Jan</creatorcontrib><creatorcontrib>Chovanec, Vendelin</creatorcontrib><creatorcontrib>Ferko, Alexander</creatorcontrib><creatorcontrib>Hoffmann, Petr</creatorcontrib><creatorcontrib>Ryška, Pavel</creatorcontrib><creatorcontrib>Renc, Ondrej</creatorcontrib><creatorcontrib>Krajina, Antonin</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><jtitle>Central European journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raupach, Jan</au><au>Vojacek, Jan</au><au>Lojik, Miroslav</au><au>Harrer, Jan</au><au>Chovanec, Vendelin</au><au>Ferko, Alexander</au><au>Hoffmann, Petr</au><au>Ryška, Pavel</au><au>Renc, Ondrej</au><au>Krajina, Antonin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term experience with endovascular therapy of the descending thoracic aorta</atitle><jtitle>Central European journal of medicine</jtitle><stitle>cent.eur.j.med</stitle><date>2013-04-01</date><risdate>2013</risdate><volume>8</volume><issue>2</issue><spage>257</spage><epage>265</epage><pages>257-265</pages><issn>1895-1058</issn><issn>2391-5463</issn><eissn>1644-3640</eissn><eissn>2391-5463</eissn><abstract>Background
To review single centre experience of endovascular treatment of descending thoracic aorta.
Methods
Between May 1999 and September 2012, 72 patients were treated overall (53 men, 19 women, mean age 60.1 years) for degenerative aneurysms (n = 5), ruptured aneurysms (n = 4), aortic ulcers (n = 8), infected aneurysms (n = 4), type B aortic dissections (n = 23), and traumatic aortic injuries (n = 28).
Results
The technical success rate was 98.6%, 30-day mortality was 8.3%, 1-year mortality was 13.8%, and overall mortality was 22.2%. Mortality caused by the treatment of aortic diseases was 6.9%. Permanent stroke occurred in 1 patient, and paraplegia developed in 1 patient. In a group of 23 patients whose left subclavian artery (LSA) was covered, claudication of the left upper extremity developed in 2 cases.
Conclusions
Endovascular therapy offers a very effective and less invasive alternative to the surgical approach for a wide range of the thoracic aortic disease. The main advantage of using TEVAR seems to be in acute conditions when a stent graft stabilizes the aorta and prevents further bleeding and organ ischemia. Regular follow-up is mandatory for early recognition of specific TEVAR complications.</abstract><cop>Heidelberg</cop><pub>SP Versita</pub><doi>10.2478/s11536-012-0117-6</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1895-1058 |
| ispartof | Central European journal of medicine, 2013-04, Vol.8 (2), p.257-265 |
| issn | 1895-1058 2391-5463 1644-3640 2391-5463 |
| language | eng |
| recordid | cdi_proquest_journals_1271850489 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Walter De Gruyter: Open Access Journals; Alma/SFX Local Collection |
| subjects | Aneurysm Aortic trauma Biomedicine Complications Dissection Internal Medicine Maternal and Child Health Medicine Medicine & Public Health Reproductive Medicine Research Article Stent graft Surgery Thoracic aorta |
| title | Long-term experience with endovascular therapy of the descending thoracic aorta |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T06%3A47%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20experience%20with%20endovascular%20therapy%20of%20the%20descending%20thoracic%20aorta&rft.jtitle=Central%20European%20journal%20of%20medicine&rft.au=Raupach,%20Jan&rft.date=2013-04-01&rft.volume=8&rft.issue=2&rft.spage=257&rft.epage=265&rft.pages=257-265&rft.issn=1895-1058&rft.eissn=1644-3640&rft_id=info:doi/10.2478/s11536-012-0117-6&rft_dat=%3Cproquest_cross%3E2871166191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1271850489&rft_id=info:pmid/&rfr_iscdi=true |